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If promulgated as origi­
nally proposed, ‘short­
sighted’ changes to the 
Medical Schemes Act, 
in par ticular sections of 
Regulation 8, will financially hurt both 
bene ficiaries of medical schemes and many 
private practitioners – via inadequate 
funder payments for prescribed minimum 
benefits (PMBs).
In spite of reassurances to the contrary 
by both the Board of Healthcare Funders 
(BHF) and Dr Anban Pillay, Deputy 
Director-General for Health Regulation and 
Compliance Management at the National 
Department of Health (NDoH), most doctor 
groups remain deeply wary of the arbitrary 
way in which medical aid rates have been 
linked to ‘deeply flawed’ 2006 National 
Health Reference Price List (NHRPL) tariffs 
(adjusted for the consumer price index (CPI)). 
The proposed legal amendment, induced by 
decade-long pricing strife and intransigence 
on the part of most stakeholders in the 
private healthcare sector, errs on the side of 
funders, allowing (but not obliging) them to 
negotiate tariffs with any healthcare provider 
for which no co-payment or deductible is 
payable by the member. PMBs cover both 
chronic and catastrophic conditions suffered 
by medical scheme members and are 
intended to offer them a measure of financial 
protection. However, since the ‘provider-cost 
deficient’ 2006 NHRPL list was drawn up, 
there have been numerous advancements 
in medical technology and procedures that 
are not included. This means that unless 
it is updated, patients stand to no longer 
be funded for optimal and up-to-date 
treatment.
Where’s the science? – 
SAMA
Dr Mzukisi Grootboom, Chairman of the 
17 000-member South African Medical 
Asso ciation (SAMA), says the amendment is 
‘difficult to explain’, given that the Minister 
of Health failed to give the profession and 
patients the scientific basis upon which he is 
proposing the amendments.
The oft-heard rhetoric, both from funders 
and politicians, was that ‘paying in full’ (the 
existing and historically much-contested 
regulatory wording for PMBs) amounted 
to a ‘blank cheque’ for doctors. However, 
the truth was that this would ‘unfortunately 
affect not only our patients but also a lot 
of colleagues in private practice by forcing 
them to charge prices at a level below the 
cost of running their practices’.
Grootboom contends that the minority of 
doctors who funders claim charge way more 
than the average medical scheme rates, or 
who fraudulently abuse the system, can easily 
be identified and held to account. Using 
this minority to justify legislation based 
on an outdated, flawed and unscientific 
price list would simply chase doctors out 
of the profession. Any further erosion of 
the widening historical gap between what 
medical aids pay doctors and what it costs 
doctors to deliver services would damage 
overall healthcare delivery, threatening the 
very existence of private practice. Doctors 
in private practice, who a reading of the 
latest Council for Medical Schemes (CMS) 
annual report showed charged on average 
between 80% and 150% of medical aid rates, 
would ‘simply leave the profession, change 
professions or go overseas’, he claimed. 
Grootboom said that feedback from the 
funding industry was that medical aids were 
only prepared to pay an ‘unsustainable’ 30% 
of the costs of running a medical practice. 
He described those few GPs and (mainly) 
consultants who charged three or four times 
the medical aid rates as ‘outliers’, stressing 
that there were mechanisms in the current 
system to deal with them, ‘particularly those 
medical aids that have well-resourced IT 
platforms and can document practices that 
grossly abuse. There is also the HPCSA 
[Health Professions Council of South Africa] 
that can deal with unethical conduct,’ he 
added.
Definition of ‘pay in full’ 
remains unresolved
Health minister Dr Aaron Motsoaledi, chief 
architect of the proposed amendment to 
Regulation 8 of the Medical Schemes Act, 
and the BHF (which warmly welcomes 
the change) claim that doctors do have 
a ‘blank cheque’ under the current Act. 
For a variety of complex legal reasons, no 
court has yet ruled on or engaged with 
all the facts behind whether the legislator 
meant that medical aids must ‘pay in 
full’ what the doctor charges – or what 
medical schemes set as payment rates. In 
practice it is the patient who most often 
suffers, paying for the shortfall regardless 
of whose interpretation pertains on the 
day. Motsoaledi’s draft tries to introduce 
greater certainty by linking medical aid 
rates to the 2006 NHRPL tariffs (adjusted 
for the CPI). Healthcare economist Alex 
van den Heever warns that if passed, the 
amendment will not only reduce financial 
risks for medical schemes but shift the 
cost burden further onto consumers – who 
have virtually no power to negotiate with 
healthcare providers.
Van den Heever, Chair of Social Security 
Administration and Management Studies 
at the University of the Witwatersrand 
School of Governance, said that ‘no 
country in the world expects consumers 
to fight at the point of service about a 
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price for healthcare’, and described the 
regulations as ‘a gift to vested interests’. 
Pillay said that the aim of the draft 
regulation is to protect medical schemes 
from open-ended liability for PMB claims. 
At the BHF annual conference held in 
Cape Town in July, he told delegates 
that a recent overview of private health 
insurance in South Africa (SA) by the 
Organisation for Economic Co-operation 
and Development (OECD – 34 countries 
with market economies) showed that SA 
was second only to the USA in respect of 
high prices.
Pillay rolls out evidence of ‘abuse’
Displaying a graph of local healthcare 
provider billing for PMBs v. non-PMBs, 
Pillay said that the variance dramatically 
illustrated how providers hiked their bills 
for PMBs: ‘Ít’s like walking into a restaurant 
and there are no prices on the menu. The 
waiter says, “Choose what you like, but 
when you leave I’ll decide what you have 
to pay.”’ He said the current system meant 
that funders had to pay whatever was billed, 
with no opportunity to negotiate. While 
he agreed that a small subset of healthcare 
providers was abusing the payment system, 
he said this had ‘a massive impact’ on 
the medical schemes involved. ‘It’s about 
dealing with this behaviour and its impact. 
More and more providers will start doing 
it – until it becomes the norm. We want a 
reimbursement system that is fair to both 
patients and providers, and one that results 
in no co-payments,’ he asserted.
He claims that the CMS will protect 
consumers by not approving medical 
schemes’ benefit packages if they fail to make 
adequate provision for members.
Grootboom and his colleagues believe 
that one of the chief motivations behind 
the current Competitions Commission 
Healthcare Inquiry is to find reasons to 
justify price control. They cite the current 
amendment as strong circumstantial 
proof of this, and have launched a 
patient advocacy campaign outlining the 
‘iniquitous history’ behind the NRHPL 
from the time medical aids began in SA 
(in 1947) to the ‘discredited’ changes in 
2006 to the proposed set-up. SAMA says 
that the 2006 schedule was ‘anything but’ 
the cost-based tariff it was disingenuously 
disguised as, and was implemented 
despite loud protestations by healthcare 
professionals. Not only did it fail to reflect 
realistic prevailing costs at the time, but 
the technological and scientific advances in 
healthcare had resulted in more than 1 000 
new services becoming available since 2006. 
The net result was that ‘the public needs to 
understand that doctors cannot be expected 
to charge for their services at below the cost 
of running their practices’.
Amendment threatens private 
practice – as we know it
‘We have to make a living, and the unin-
tended consequence of this is that those 
who remain in the profession have to work 
longer hours while still being unable to fund 
their retirement. A few [doctors] have even 
resorted to unacceptable and/or fraudulent 
behaviour, driven by trying to make ends 
meet. The most shocking thing about this is 
that we’ve yet to see any evidence of alleged 
widespread abuse or trends. It would be far 
more helpful if the NDoH, rather than play 
politics while dancing to the tune of different 
funders, showed us the evidence’.
Dr Tony Behrman, CEO of the Inde-
pendent Practitioners Association Found-
a tion, predicts that if passed ‘as is’, the 
amendment will result in healthcare 
providers quickly agreeing to charge what 
medical schemes are willing to pay – because 
patients will simply refuse to pay out of their 
own pockets. ‘The market will rule, and 
specialists and hospitals will find their bills 
remain unpaid because the average South 
African can’t afford the excess,’ he said.
Pillay conceded that neither doctors nor 
hospitals were consulted, explaining ‘this 
is our attempt to solve the problem – we’re 
wide open to alternatives over the next 3 
months while the draft is open for comment 
and input’.
Grootboom said that one of the key 
failures of the legislative funding framework 
was the lack of a risk equalisation fund and 
enforced enrolment (where all employees 
have to contribute towards a fund to widen 
the risk pool). ‘Somebody needs to monitor 
how much burden of disease a scheme is 
dealing with and then set aside a relevant 
risk fund. These are all key deficiencies – the 
minister, for political reasons, is actually 
missing the point.’
Patient advocacy group Section 27 said 
that the proposed amendment was a ‘step 
backwards’ and diminished patient access 
to healthcare services, pushing more South 
Africans towards dysfunctional public 
healthcare. Several patient advocacy groups, 
SAMA and the South African Private 
Practitioners Forum (SAPPF) believe 
that the amendment is unconstitutional. 
SAPPF CEO Dr Clive Archer said that the 
NDoH’s submission to the Competition 
Commission inquiry spoke about an 
independently produced, cost-based tariff. 
This was at wide variance with the proposed 
legal amendment. ‘The Department’s health 
inquiry submission recommends that the 
state establish a negotiation framework to 
support collective bargaining using a cost-
based structure as a point of departure,’ 
he said. Archer described the proposed 
amendment as ‘retrogressive, undermining 
the whole ethos of the current system, 
which is to protect families from massive 
medical expenses and prevent dumping on 
the state’.
Anaesthetists awaken colleagues  
to another problem
Meanwhile, the South African Society of 
Anaes thesiologists said that another amend-
ment to Regulation 5 of the Medical Schemes 
Act, while less publicly reported, required 
attending doctors to provide a ‘discharge 
summary’ to medical schemes for all 
ailments, including PMB conditions, for 
hospital and doctor (potentially all medical) 
bills. While medical bills could be submitted 
at present using multiple digital platforms, 
these summaries were not catered for in 
current medical scheme systems. There was 
therefore ‘every possibility and likelihood’ 
that schemes would simply not reimburse 
medical practitioners ‘for months or years’, 
pending finalisation of such reports. These 
reports may also contain patient confidential 
information the sharing of which requires 
specific consent. Grootboom said that this 
lent statutory authority to an already worrying 
trend among medical schemes to get doctors 
to perform administrative functions on 
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their behalf. SAMA was examining the legal 
validity of all the intended amendments, as 
well as the practical implications for both its 
members and their patients, and would soon 
be submitting this to the minister.
BHF chair Dr Clarence Mini, speaking at 
the end of the July conference, said that BHF-
initiated task teams would focus on ‘inclusive 
solutions and consensus’ during the draft 
amendment input period. He appealed to all 
service providers to take part in creating a 
‘road map’ that would provide fair remuneration 
to all parties and avoid patients sitting with 
co-payments. The BHF has been in tariff 
negotiations with the South African Dental 
Association (SADA) for the past 18 months, 
and recently met with SADA to evaluate coding 
changes and set up a risk advisory panel. Pushed 
on when the ‘road map’ would be finalised, 
Mini said that a draft would ‘probably be ready 
between mid-September and mid-October’, 
describing it as ‘open-ended’.
Chris Bateman
chrisb@hmpg.co.za
S Afr Med J 2015;105(7):704-706.  
DOI:10.7196/SAMJnew.8560
Healthcare prices architect in last­gasp appeal
A former legal adviser to the CMS, who drew up the much-contested 2006 NHRPL, has told 
healthcare providers and funders to ‘man-up’ and bury the hatchet – or face ceding pricing 
control to government.
Stephen Harrison, a 9-year veteran of the CMS (2000 - 2009), has watched with growing 
exasperation for more than a decade as the players now suddenly and potentially most 
affected by his price referencing (in terms of the new Regulation 8 amendment) continue to 
grandstand while failing to move towards any solution or mutual accommodation.
Now a lecturer in emergency medicine at the Cape Peninsula University of Technology, 
Harrison bluntly told the July BHF conference that the ‘degree of hopelessness and despair’ 
displayed in the private healthcare industry’s submissions to the Competitions Commission 
healthcare inquiry invited ‘a radical interventionist approach’ from government.
With the Regulation 8 amendment – probably due for enactment early next year – now 
basing PMB pricing on the 2006 NHRPL and, in his opinion, likely to benefit funders at the 
cost of patients and providers, his message to delegates was clear.
‘For goodness’ sake, let’s actually resolve this impasse and come up with a practical solution. This is an opportunity for a small group 
of leaders in the health sector to come together. The publication of the amendment provides an opportunity to do that. I’m not optimistic 
that this [regulation] is a sustainable way forward – historically we’ve never addressed the heart of the problem, we’ve just introduced more 
subterfuge in the industry. We need a reality check – and to admit that we’re now at a crossroads.’ Earlier he had said that private healthcare 
sector leaders needed to ‘stand up … remember we’re all in this boat together’.
While he accepted the bona fides of the NDoH in introducing the legislative amendment to attain a greater degree of certainty in the 
market – and that it did not intend to increase co-payments by patients – the net effect of Regulation 8 would be to create greater disparity 
between what providers charged and what medical schemes paid. The gap cover market would burgeon, and patients would either be denied 
care or revert to the public sector.
‘You can argue the long-term reductionist effect on premiums (as schemes save on PMB payout amounts), but the crunch will come when 
the consumer gets ill and needs cover for PMBs. The original intention for PMBs has been lost. If you go back to the Memorandum on the 
Objects of the Medical Schemes Bill of 1998, this was to protect necessary and cost-effective care and not to shift patients arbitrarily to a 
public hospital when their benefits are depleted.’ The amendment would create a significant barrier to necessary care and flouted Section 2 
in the Constitutional protection of Section 27 – that government would take reasonable, progressive legislative and other measures within 
its resources to achieve the progressive realisation of access to healthcare. ‘To me this is a retrogressive step in the protection of rights of 
consumers. The main roleplayers are intractable and in significantly dug-in positions,’ he stressed. The protagonists needed to move from 
unilateral action, confrontation and ‘adversarialism’ to joint problem-solving, from competition for slices of the pie to a focus on enlarging 
the pie, and from entrenched respective positions to respective interests as departure points. Harrison advocated ‘Codesa-type’ talks between 
the adversaries, saying that SA had a rich history of resolving seemingly impossible disputes.
‘Get it together’ – ex-CMS lawyer Stephen Harrison.
